A new HIV pill, VH-499, has demonstrated significant success in its first human trial, effectively lowering HIV-1 levels in 23 participants.
The drug utilizes a novel scientific mechanism that researchers believe could offer a more efficient treatment path for patients living with the virus.
Following these positive initial results, the medical team is preparing for larger-scale clinical trials to confirm the pill's long-term safety and efficacy.